{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:19:10Z","timestamp":1789445950647,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.pop.2024.03.006","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:51:35Z","timestamp":1716493895000},"page":"483-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multiple Endocrine Neoplasia Type 1, Type 2A, and Type 2B"],"prefix":"10.1016","volume":"51","author":[{"given":"Leslie A.","family":"Greenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pop.2024.03.006_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12020-017-1234-4","article-title":"Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database","volume":"58","author":"Giusti","year":"2017","journal-title":"Endocrine"},{"issue":"9","key":"10.1016\/j.pop.2024.03.006_bib2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/qjmed\/89.9.653","article-title":"Clinical studies of multiple endocrine neoplasia type 1 (MEN1)","volume":"89","author":"Trump","year":"1996","journal-title":"QJM"},{"issue":"6","key":"10.1016\/j.pop.2024.03.006_bib3","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.beem.2018.09.010","article-title":"Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism","volume":"32","author":"Cristina","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"10","key":"10.1016\/j.pop.2024.03.006_bib4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archsurg.134.10.1119","article-title":"Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy","volume":"134","author":"Burgess","year":"1999","journal-title":"Arch Surg"},{"issue":"11","key":"10.1016\/j.pop.2024.03.006_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJM199003153221103","article-title":"Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome","volume":"322","author":"Pipeleers-Marichal","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.pop.2024.03.006_bib6","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"8","key":"10.1016\/j.pop.2024.03.006_bib7","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/imj.14394","article-title":"Multiple endocrine neoplasia: an update","volume":"49","author":"McDonnell","year":"2019","journal-title":"Int Med J"},{"issue":"12","key":"10.1016\/j.pop.2024.03.006_bib8","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.pop.2024.03.006_bib9","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2147\/CLEP.S174606","article-title":"Incidence and prevalence of multiple endocrine neoplasia 2A in Denmark 1901-2014: a nationwide study","volume":"10","author":"Mathiesen","year":"2018","journal-title":"Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.pop.2024.03.006_bib10","doi-asserted-by":"crossref","first-page":"L39","DOI":"10.1530\/ERC-17-0122","article-title":"Incidence and prevalence of multiple endocrine neoplasia 2B in Denmark: a nationwide study","volume":"24","author":"Mathiesen","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"10.1016\/j.pop.2024.03.006_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2265.1998.00392.x","article-title":"Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients","volume":"48","author":"Modigliani","year":"1998","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.pop.2024.03.006_bib12","first-page":"233","article-title":"Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d\u2019Etude des Tumeurs a Calcitonine","volume":"60","author":"Schuffenecker","year":"1997","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.pop.2024.03.006_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-8587(18)30336-X","article-title":"Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study","volume":"7","author":"Castinetti","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.pop.2024.03.006_bib14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/SLA.0b013e3182a6f43a","article-title":"Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective","volume":"259","author":"Brauckhoff","year":"2014","journal-title":"Ann Surg"},{"issue":"Suppl 1","key":"10.1016\/j.pop.2024.03.006_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.6061\/clinics\/2012(Sup01)13","article-title":"Genotype-phenotype correlation in multiple endocrine neoplasia type 2","volume":"67","author":"Raue","year":"2012","journal-title":"Clinics"},{"issue":"2","key":"10.1016\/j.pop.2024.03.006_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0092-8674(85)90115-1","article-title":"Activation of a novel human transforming gene, ret, by DNA rearrangement","volume":"42","author":"Takahashi","year":"1985","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.pop.2024.03.006_bib17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s001090050065","article-title":"Expression of the RET proto-oncogene in normal human tissues, pheochromocytomas, and other tumors of neural crest origin","volume":"74","author":"Takaya","year":"1996","journal-title":"J\u00a0Mol Med (Berl)"},{"issue":"6","key":"10.1016\/j.pop.2024.03.006_bib18","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.surg.2003.08.005","article-title":"Critical size of residual adrenal tissue and recovery from impaired early postoperative adrenocortical function after subtotal bilateral adrenalectomy","volume":"134","author":"Brauckhoff","year":"2003","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.pop.2024.03.006_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jjco\/27.3.128","article-title":"A\u00a0Nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan","volume":"27","author":"Lihara","year":"1997","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"10.1016\/j.pop.2024.03.006_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00000658-199409000-00002","article-title":"Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A","volume":"220","author":"Wells","year":"1994","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.pop.2024.03.006_bib21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10689-016-9892-6","article-title":"MEN 2A related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics","volume":"15","author":"Scapineli","year":"2016","journal-title":"Fam Cancer"},{"issue":"1","key":"10.1016\/j.pop.2024.03.006_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5603\/EP.2016.0008","article-title":"Occurrence of phaeochromocytoma tumours in RET mutation carriers \u2014 a single-centre study","volume":"67","author":"Kotecka-Blicharz","year":"2016","journal-title":"Endokrynol Pol"},{"issue":"1","key":"10.1016\/j.pop.2024.03.006_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1824-7288-38-9","article-title":"Multiple endocrine neoplasias type 2B and RET proto-oncogene","volume":"38","author":"Martucciello","year":"2012","journal-title":"Ital J Pediatr"},{"issue":"2","key":"10.1016\/j.pop.2024.03.006_bib24","first-page":"141","article-title":"Pheochromocytoma: implications in tumorigenesis and the actual management","volume":"37","author":"Shah","year":"2012","journal-title":"Minerva Endocrinol"},{"issue":"1","key":"10.1016\/j.pop.2024.03.006_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.pop.2024.03.006_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1634\/theoncologist.2007-0239","article-title":"Current Management of Medullary Thyroid Cancer","volume":"13","author":"Sippel","year":"2008","journal-title":"Oncol"},{"key":"10.1016\/j.pop.2024.03.006_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.semcancer.2021.03.035","article-title":"Multiple endocrine neoplasia type 2: A review","volume":"79","author":"Mathiesen","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10.1016\/j.pop.2024.03.006_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1210\/jc.2017-01884","article-title":"Long-term survivorship in multiple endocrine neoplasia type 2B diagnosed before and in the new millennium","volume":"103","author":"Raue","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"19","key":"10.1016\/j.pop.2024.03.006_bib29","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA, J Am Med Assoc"},{"issue":"7","key":"10.1016\/j.pop.2024.03.006_bib30","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jpedsurg.2016.10.054","article-title":"Identification of intestinal ganglioneuromatosis leads to early diagnosis of MEN2B: role of rectal biopsy","volume":"52","author":"Gfroerer","year":"2017","journal-title":"J\u00a0Pediatr Surg"},{"issue":"2","key":"10.1016\/j.pop.2024.03.006_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.14310\/horm.2002.1227","article-title":"Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome","volume":"8","author":"Pacak","year":"2009","journal-title":"Hormones (Basel)"},{"issue":"1","key":"10.1016\/j.pop.2024.03.006_bib32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00268-020-05759-w","article-title":"Posterior Retroperitoneoscopic versus laparoscopic transperitoneal adrenalectomy: a systematic review by an updated meta-analysis","volume":"45","author":"Gavriilidis","year":"2021","journal-title":"World J Surg"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454324000186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454324000186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T10:33:57Z","timestamp":1721990037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454324000186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0095454324000186"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2024.03.006","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple Endocrine Neoplasia Type 1, Type 2A, and Type 2B","name":"articletitle","label":"Article Title"},{"value":"Primary Care: Clinics in Office Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pop.2024.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}